User profiles for Carmen L. Charlton

Carmen Charlton

University of Alberta
Verified email at ualberta.ca
Cited by 2824

A new SARS-CoV-2 dual-purpose serology test: highly accurate infection tracing and neutralizing antibody response detection

SC Taylor, B Hurst, CL Charlton, A Bailey… - Journal of clinical …, 2021 - Am Soc Microbiol
Many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serology tests have
proven to be less accurate than expected and do not assess antibody function as neutralizing…

Practical guidance for clinical microbiology laboratories: viruses causing acute respiratory tract infections

CL Charlton, E Babady, CC Ginocchio… - Clinical microbiology …, 2018 - Am Soc Microbiol
Respiratory viral infections are associated with a wide range of acute syndromes and
infectious disease processes in children and adults worldwide. Many viruses are implicated in …

Evaluation of six commercial mid-to high-volume antibody and six point-of-care lateral flow assays for detection of SARS-CoV-2 antibodies

CL Charlton, JN Kanji, K Johal, A Bailey… - Journal of clinical …, 2020 - Am Soc Microbiol
Coronavirus disease (COVID) serological tests are essential to determine the overall
seroprevalence of a population and to facilitate exposure estimates within that population. We …

[HTML][HTML] Pseudomonas aeruginosa minor pilins prime type IVa pilus assembly and promote surface display of the PilY1 adhesin

…, H Harvey, SD Bell, CL Charlton… - Journal of Biological …, 2015 - ASBMB
Type IV pili (T4P) contain hundreds of major subunits, but minor subunits are also required
for assembly and function. Here we show that Pseudomonas aeruginosa minor pilins prime …

[HTML][HTML] Label-free impedimetric immunosensor for point-of-care detection of COVID-19 antibodies

…, R Zhuo, J Zeng, Y Feng, CL Charlton… - Microsystems & …, 2023 - nature.com
The COVID-19 pandemic has posed enormous challenges for existing diagnostic tools to
detect and monitor pathogens. Therefore, there is a need to develop point-of-care (POC) …

Comparison of the Vitek MS and Bruker Microflex LT MALDI-TOF MS platforms for routine identification of commonly isolated bacteria and yeast in the clinical …

E Deak, CL Charlton, AM Bobenchik, SA Miller… - … and infectious disease, 2015 - Elsevier
This study compared the diagnostic performance of Bruker's Microflex LT and bioMérieux's
Vitek MS matrix-assisted laser desorption ionization–time of flight mass spectrometry systems…

Performance of Vitek 2 for antimicrobial susceptibility testing of Enterobacteriaceae with Vitek 2 (2009 FDA) and 2014 CLSI breakpoints

…, E Deak, JA Hindler, CL Charlton… - Journal of clinical …, 2015 - Am Soc Microbiol
Vitek 2 (bioMérieux Inc., Durham, NC) is a widely used commercial antimicrobial susceptibility
test system. We compared the MIC results obtained using the Vitek 2 AST-GN69 and AST-…

Performance of Vitek 2 for antimicrobial susceptibility testing of Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia with Vitek 2 …

…, E Deak, JA Hindler, CL Charlton… - Journal of clinical …, 2017 - Am Soc Microbiol
The performances of Vitek 2 AST-GN69 and AST-XN06 cards were compared to Clinical and
Laboratory Standards Institute (CLSI) reference broth microdilution (BMD) for 99 isolates of …

Pre-vaccine positivity of SARS-CoV-2 antibodies in Alberta, Canada during the first two waves of the COVID-19 pandemic

CL Charlton, LT Nguyen, A Bailey, J Fenton… - Microbiology …, 2021 - Am Soc Microbiol
We systematically evaluated SARS-CoV-2 IgG positivity in a provincial cohort to understand
the local epidemiology of COVID-19 and support evidence-based public health decisions. …

In Vitro Activity of Daptomycin in Combination with β-Lactams, Gentamicin, Rifampin, and Tigecycline against Daptomycin-Nonsusceptible Enterococci

JA Hindler, A Wong-Beringer, CL Charlton… - Antimicrobial agents …, 2015 - Am Soc Microbiol
Enterococci that are nonsusceptible (NS; MIC > 4 μg/ml) to daptomycin are an emerging
clinical concern. The synergistic combination of daptomycin plus beta-lactams has been shown …